Is the Options Market Predicting a Spike in Integra LifeSciences Stock?

Company Overview - Integra LifeSciences Holdings Corporation (IART) is currently experiencing significant attention from investors due to high implied volatility in its options market, particularly the Jun 20, 2025 $20.00 Call option [1] - The company is ranked 4 (Sell) by Zacks in the Medical - Instruments Industry, which is in the top 36% of the Zacks Industry Rank [3] Analyst Sentiment - Over the past 60 days, no analysts have increased their earnings estimates for the current quarter, while five analysts have revised their estimates downward, leading to a decrease in the Zacks Consensus Estimate from 59 cents per share to 43 cents [3] Market Expectations - The high implied volatility suggests that options traders are anticipating a significant price movement for Integra LifeSciences shares, potentially indicating an upcoming event that could lead to a major rally or sell-off [2][4] - Options traders often seek to sell premium on options with high implied volatility, aiming to benefit from the decay of the option's value if the underlying stock does not move as much as expected [4]